Cargando…
In silico trial to test COVID-19 candidate vaccines: a case study with UISS platform
BACKGROUND: SARS-CoV-2 is a severe respiratory infection that infects humans. Its outburst entitled it as a pandemic emergence. To get a grip on this outbreak, specific preventive and therapeutic interventions are urgently needed. It must be said that, until now, there are no existing vaccines for c...
Autores principales: | Russo, Giulia, Pennisi, Marzio, Fichera, Epifanio, Motta, Santo, Raciti, Giuseppina, Viceconti, Marco, Pappalardo, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733700/ https://www.ncbi.nlm.nih.gov/pubmed/33308153 http://dx.doi.org/10.1186/s12859-020-03872-0 |
Ejemplares similares
-
Moving forward through the in silico modeling of tuberculosis: a further step with UISS-TB
por: Russo, Giulia, et al.
Publicado: (2020) -
Generation of digital patients for the simulation of tuberculosis with UISS-TB
por: Juárez, Miguel A., et al.
Publicado: (2020) -
Predicting the artificial immunity induced by RUTI® vaccine against tuberculosis using universal immune system simulator (UISS)
por: Pennisi, Marzio, et al.
Publicado: (2019) -
Agent-Based Modeling of the Immune System: NetLogo, a Promising Framework
por: Chiacchio, Ferdinando, et al.
Publicado: (2014) -
Verification of an agent‐based disease model of human Mycobacterium tuberculosis infection
por: Curreli, Cristina, et al.
Publicado: (2021)